Dan Zandberg
Clinical trials sponsored by Dan Zandberg, explained in plain language.
-
Experimental drug combo aims to boost immunotherapy in tough cancers
Disease control OngoingThis study tests an experimental drug called ARRY-614 combined with standard immunotherapy drugs (nivolumab or nivolumab plus ipilimumab) in people with advanced solid tumors, including lung, head and neck, kidney, and skin cancers. The first part of the trial finds a safe dose, …
Phase: PHASE1, PHASE2 • Sponsor: Dan Zandberg • Aim: Disease control
Last updated Jun 22, 2026 11:59 UTC
-
New drug cocktail shows promise in shrinking head and neck tumors before surgery
Disease control OngoingThis study tests whether giving immune-boosting drugs before surgery can help shrink head and neck cancer tumors. About 80 adults with advanced but removable cancer will receive either nivolumab alone or combined with relatlimab or ipilimumab. Researchers will monitor side effect…
Phase: PHASE2 • Sponsor: Dan Zandberg • Aim: Disease control
Last updated Jun 03, 2026 12:04 UTC